Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Bioscience    crawled time : 15:00    save search

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
CBIH | $0.0006 -62.5% 600K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: 0.0% H: 33.33% C: 16.67%

cannabis advantage bioscience international
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-18 (Crawled : 15:00) - biospace.com/
TWST | $31.505 6.98% 6.51% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 2.67% C: -0.75%

conference bioscience
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
Published: 2023-11-28 (Crawled : 15:00) - invobioscience.com
INVO | $1.29 4.03% 3.88% 610K twitter stocktwits trandingview |
Health Technology
| | O: -4.33% H: 2.51% C: -8.04%

nasdaq bioscience
Daré Bioscience to Host Third Quarter 2023 Financial Results and Company Update Conference Call and Webcast on November 9, 2023
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
DARE | $0.306 3.62% 3.5% 320K twitter stocktwits trandingview |
Health Technology
| | O: 7.32% H: 0.0% C: -10.68%

conference company bioscience update financial results
Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3598 18.14% 15K twitter stocktwits trandingview |
n/a
| | O: 5.78% H: 2.07% C: 2.07%

sat-3153 fda drug bioscience designation duchenne
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
Published: 2023-07-18 (Crawled : 15:00) - biospace.com/
TWST | $31.505 6.98% 6.51% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 5.08% C: 3.68%

bioscience cancer research collaboration
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
Published: 2023-07-05 (Crawled : 15:00) - biospace.com/
PURE | $0.08 1.01% 74K twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 6.25% C: 0.0%

association food bioscience international meeting program
Satellos Bioscience Announces Appointment of Chief Medical Officer
Published: 2023-06-07 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3598 18.14% 15K twitter stocktwits trandingview |
n/a
| | O: 0.55% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.0% C: 0.0%

bioscience medical
Satellos Bioscience Announces Grant of Stock Options
Published: 2023-06-01 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3598 18.14% 15K twitter stocktwits trandingview |
n/a
| | O: -6.67% H: 0.0% C: 0.0%

bioscience grant
Satellos Bioscience Inc. Announces Pricing of Public Offering
Published: 2023-04-19 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3598 18.14% 15K twitter stocktwits trandingview |
n/a
| | O: -0.19% H: 7.82% C: 7.82%

bioscience offering
Skye Bioscience Receives Positive Safety Review of Third Cohort in Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-04-04 (Crawled : 15:00) - biospace.com/
SKYE | $14.015 -5.37% -5.67% 140K twitter stocktwits trandingview |
Transportation and Warehousing
| | O: -1.33% H: 17.57% C: 14.86%

sbi-100 review positive bioscience study
Skye Bioscience Doses Third Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
Published: 2023-03-07 (Crawled : 15:00) - biospace.com/
SKYE | $14.015 -5.37% -5.67% 140K twitter stocktwits trandingview |
Transportation and Warehousing
| | O: -9.67% H: 10.33% C: 7.01%

sbi-100 trial bioscience ophthalmic emulsion phase 1
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference
Published: 2023-02-22 (Crawled : 15:00) - biospace.com/
AADI | $1.845 -2.9% -2.98% 84K twitter stocktwits trandingview |
Manufacturing
| | O: -0.09% H: 2.43% C: -1.39%

conference bioscience
Daré Bioscience Announces Start of a Phase 1 Study for its Potential First-in-Category Treatment for Primary Dysmenorrhea, DARE-PDM1
Published: 2023-02-22 (Crawled : 15:00) - biospace.com/
DARE | $0.306 3.62% 3.5% 320K twitter stocktwits trandingview |
Health Technology
| | O: 0.93% H: 4.59% C: -1.83%

treatment potential bioscience study phase 1
Yield10 Bioscience Announces Key Advancements in the Development of Herbicide Tolerant Camelina Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
Published: 2023-02-21 (Crawled : 15:00) - globenewswire.com
YTEN | $0.2482 -4.9% -5.16% 370K twitter stocktwits trandingview |
Health Technology
| | O: -1.84% H: 2.94% C: 1.07%

bioscience market
Skye Bioscience Appoints Deborah Charych, PhD to Board of Directors
Published: 2023-02-16 (Crawled : 15:00) - biospace.com/
SKYE | $14.015 -5.37% -5.67% 140K twitter stocktwits trandingview |
Transportation and Warehousing
| | O: -0.26% H: 4.17% C: -4.95%
NKTR | News | $1.415 4.04% 3.89% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.57% H: 1.32% C: -1.65%

bioscience
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Published: 2023-01-27 (Crawled : 15:00) - biospace.com/
SKYE | $14.015 -5.37% -5.67% 140K twitter stocktwits trandingview |
Transportation and Warehousing
| | O: 3.57% H: 10.0% C: -1.72%

sbi-100 trial approval bioscience phase 2 ophthalmic emulsion
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1
Published: 2023-01-26 (Crawled : 15:00) - biospace.com/
DARE | $0.306 3.62% 3.5% 320K twitter stocktwits trandingview |
Health Technology
| | O: 2.24% H: 2.19% C: -0.73%

trial bioscience publication phase 1
Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update
Published: 2022-11-09 (Crawled : 15:00) - biospace.com/
AADI | $1.845 -2.9% -2.98% 84K twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 3.91% C: 2.84%

financial bioscience update
Satellos Bioscience Inc. Announces the Grant of Stock Options
Published: 2022-10-07 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3598 18.14% 15K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

grant bioscience
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.